![Shaun Furlong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 142 $ al 30/06/2026
Shaun Furlong is currently the Chief Financial Officer & Executive Director at Allergy Therapeutics Plc.
He started this position in 2022 and his job is ongoing.
Dr. Furlong holds a doctorate degree from the University of Sussex.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2026 | 1.507 ( 0 % ) | 142 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ALLERGY THERAPEUTICS PLC | Director Financiero/CFO | 11/08/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Allergy Therapeutics Plc
 Allergy Therapeutics Plc Pharmaceuticals: OtherHealth Technology Manufactures subcutaneous and sublingual immunotherapy treatments for a wide range of allergic conditions | Health Technology |
University of Sussex
 University of Sussex Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
